| May 10 2023 |
HHS OIG Report: COVID-19 Testing Labs Flagged for Fraud |
Tycko & Zavareei LLP |
| May 10 2023 |
Teleprescribing of Controlled Substances Temporarily Extended Beyond Phe – What’s Next? |
McDermott Will & Schulte LLP |
| May 10 2023 |
Delta Great? Tennessee Legislature Passes Industry-Friendly Bill to Regulate Psychoactive, Hemp-Derived Cannabinoids |
Bradley Arant Boult Cummings LLP |
| May 10 2023 |
FDA Petitioned to Set Added Sugar Reduction Targets |
Keller and Heckman LLP |
| May 10 2023 |
FDA Filed Color Additive Petition Request to Revoke Listing for Use of Titanium Dioxide in Food; Notifies World Trade Organization |
Keller and Heckman LLP |
| May 10 2023 |
JRC Publishes Guidance Document on Implementation of the EC’s Revised Definition of Nanomaterials, Launches Free Course on Nanomaterials in EU Legislation |
Bergeson & Campbell, P.C. |
| May 9 2023 |
Podcast: The Legal Battle Over Mifepristone – Diagnosing Health Care [PODCAST] |
Epstein Becker & Green, P.C. |
| May 9 2023 |
Healthcare Preview For the Week Of: May 8, 2023 |
McDermott Will & Schulte LLP |
| May 8 2023 |
FDA Discusses International Food Safety Collaboration and Upcoming APEC Meetings |
Keller and Heckman LLP |
| May 5 2023 |
Roadmap to the Phased Transition Process for Medical Devices after Covid-19 Public Health Emergency |
Squire Patton Boggs (US) LLP |
| May 5 2023 |
Mcdermottplus Check-Up: May 5, 2023 |
McDermott Will & Schulte LLP |
| May 4 2023 |
FDA Seeks Comment on Request to Revoke the Color Additive Listing for Use of Titanium Dioxide in Food |
Bergeson & Campbell, P.C. |
| May 4 2023 |
EC Committee Begins Public Consultation on Preliminary Opinion on Fullerenes, Hydroxylated Fullerenes, and Hydrated Forms of Hydroxylated Fullerenes (Nano) |
Bergeson & Campbell, P.C. |
| May 4 2023 |
House Energy and Commerce Committee Introduces Food Labeling Modernization Act of 2023 |
Keller and Heckman LLP |
| May 4 2023 |
DEA to Extend Current Telemedicine Flexibilities |
Polsinelli PC |
| May 3 2023 |
AAFCO Announces Common Food Index |
Keller and Heckman LLP |
| May 3 2023 |
APHIS Releases New Strategic Plan for 2023-2027, Includes Biotechnology Objectives |
Bergeson & Campbell, P.C. |
| May 3 2023 |
Senate HELP Committee Eyes Drug Pricing and PBM Regulation Beyond Federal Programs |
Mintz |
| May 2 2023 |
CSU Announces Redesigned “Dream” Biodegradable Plastics |
Bergeson & Campbell, P.C. |
| May 2 2023 |
Court Upholds Dismissal of Lawsuit Challenging “Just Fruit” Claim |
Keller and Heckman LLP |
| May 2 2023 |
BREAKING: Seventh Circuit Affirms Dismissal of Lawsuit Alleging Violation of Genetic Right to Privacy, Rebuffing Claims Premised on Stock Purchase of Genetic Testing Company |
Squire Patton Boggs (US) LLP |
| May 2 2023 |
Unpacking Averages: Success Rates for FDA FOIAs by Topic and Requester |
Epstein Becker & Green, P.C. |
| May 2 2023 |
The Hydrogen Color Wheel: A Primer |
Blank Rome LLP |
| May 1 2023 |
EPA Denies Petition Seeking TSCA Section 4 Testing of PVA |
Bergeson & Campbell, P.C. |
| May 1 2023 |
Another Letter From Congress Complaining About Pharmaceutical Patents |
Foley & Lardner LLP |
| May 1 2023 |
SCOTUS Appears Poised To Reject Defense-Friendly Safeco Scienter Standard In FCA Cases |
Polsinelli PC |
| May 1 2023 |
Get Ready for FDA Investigations Over Semaglutide |
Oberheiden P.C. |
| May 1 2023 |
Reasonable Consumers Would Not Expect to Buy Margarita Cocktails in a New York Grocery Store |
Keller and Heckman LLP |
| Apr 28 2023 |
Moving Towards MOCRA Implementation: FDA Announces Industry “Listening Session” |
Mintz |
| Apr 28 2023 |
MCDERMOTTPLUS CHECK-UP: APRIL 28, 2023 |
McDermott Will & Schulte LLP |
| Apr 28 2023 |
FTC Puts Almost 700 Advertisers on Notice That They May Face Civil Penalties for Unsubstantiated Claims |
ArentFox Schiff LLP |
| Apr 27 2023 |
Council of the EU Approves Conclusions on the Opportunities of the Bioeconomy |
Bergeson & Campbell, P.C. |
| Apr 27 2023 |
Breaking Up Is Hard to Do: Validity Upheld Based on Expert Separation Testimony |
McDermott Will & Schulte LLP |
| Apr 27 2023 |
Digitalization of Procedures for Cosmetic Products |
OLIVARES |
| Apr 27 2023 |
USDA Proposes Declaring Salmonella an Adulterant in Breaded Stuffed Raw Chicken Products |
Keller and Heckman LLP |
